The subject of the article is to present the possibilities offered by biobanks to the development of biomedical sciences, and in particular to genetic diseases. It also shows threats with the increasing use of genetic tests, especially so-called Direct to Consumer Tests.
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.